These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8768704)

  • 21. [The specificity of action of penbutolol and propranolol and their optical isomers].
    Kaiser J
    Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
    Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of octylguanidine on heart activity: 1. Electrical cardiac response of guinea-pig as compared to Xenopus.
    Re GG; Paventa R
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):619-24. PubMed ID: 7378197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.
    Iguchi S; Iwamura H; Nishizaki M; Hayashi A; Senokuchi K; Kobayashi K; Sakaki K; Hachiya K; Ichioka Y; Kawamura M
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1462-9. PubMed ID: 1356643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the mechanism of beta-adrenergic activation of cardiac outward currents--chloride and delayed rectifier potassium conductance].
    Gadsby DC; Horie M; Makita T; Zang WJ; Suzuki H; Kawai C
    Jpn Circ J; 1992; 56 Suppl 5():1344-8. PubMed ID: 1337921
    [No Abstract]   [Full Text] [Related]  

  • 26. [Membrane stabilizing actions of befunolol and indenolol, new beta-adrenergic receptor blocking drugs (author's transl)].
    Sada H; Harada S; Kojima M; Ban T
    Kokyu To Junkan; 1981 Nov; 29(11):1231-7. PubMed ID: 6121358
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardial effects of aldosterone antagonists--electrophysiological measurements on papillary heart muscle].
    Lüderitz B; Naumann D'Alnoncourt C; Avenhaus H; Bolte HD
    Verh Dtsch Ges Inn Med; 1972; 78():1066-9. PubMed ID: 4665465
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of the combination of quinidine and lidocaine on the upstroke velocity of the cardiac action potential.
    Moyer JW; Hondeghem LM
    Proc West Pharmacol Soc; 1980; 23():159-61. PubMed ID: 7403119
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analysis of pharmacological properties of various potential beta adrenolytics of the aryloxypropanolamine type].
    Béderová E; Edelsteinová S; Racanský V; Svec P
    Cesk Farm; 1982 Sep; 31(7):279-85. PubMed ID: 6128077
    [No Abstract]   [Full Text] [Related]  

  • 30. Esmolol: a pharmacokinetic profile of a new cardioselective beta-blocking agent.
    Yacobi A; Kartzinel R; Lai CM; Sum CY
    J Pharm Sci; 1983 Jun; 72(6):710-1. PubMed ID: 6135794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of quinidine on electrical behavior in cardiac muscle.
    Prinzmetal M; Ishikawa K; Oishi H; Ozkan E; Wakayama J; Baines JM
    J Pharmacol Exp Ther; 1967 Sep; 157(3):659-64. PubMed ID: 6048022
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of alcohol on the myocardium. I. An analysis of the effects of ethanol on the bullfrog myocardium].
    Ikeda K; Hachisuga M; Goto M
    Fukuoka Igaku Zasshi; 1984 Feb; 75(2):64-71. PubMed ID: 6610618
    [No Abstract]   [Full Text] [Related]  

  • 33. Membrane currents in frog atria as affected by metabolic inhibition.
    Haas HG; Tarr M
    Pflugers Arch; 1969; 307(2):R31-2. PubMed ID: 5814836
    [No Abstract]   [Full Text] [Related]  

  • 34. Advantage of landiolol over esmolol? We doubt it!
    Frank G; Fitzgerald RD
    Eur J Clin Pharmacol; 2018 May; 74(5):671-672. PubMed ID: 29313068
    [No Abstract]   [Full Text] [Related]  

  • 35. A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart.
    Fukushima S; Miyagawa S; Sakai Y; Sawa Y
    Heart Fail Rev; 2015 Jul; 20(4):401-13. PubMed ID: 25708182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A modified procedure for estimating pA2--equi-concentration effect method].
    Xu DZ
    Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):568-71. PubMed ID: 2641859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary data on the membrane potential of gastropod zygotes in normal conditions and exposed to the action of urea].
    Meshcheriakov VN; Vorob'eva IA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1973; 114(6):47-50. PubMed ID: 4797280
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analysis of a posthumous potential in the single muscle fiber].
    Ferroni A; Blanchi D
    Boll Soc Ital Biol Sper; 1967 Dec; 43(23):1577-81. PubMed ID: 5589050
    [No Abstract]   [Full Text] [Related]  

  • 39. Welcome to ONO.
    Hoffer ME; Toh EH
    Otol Neurotol Open; 2021 Sep; 1(1):e002. PubMed ID: 38549729
    [No Abstract]   [Full Text] [Related]  

  • 40. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.
    Krumpl G; Ulc I; Trebs M; Kadlecová P; Hodisch J
    Eur J Clin Pharmacol; 2017 Apr; 73(4):417-428. PubMed ID: 28091703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.